Saul N Faust
Faust, Saul.
VIAF ID: 49163629022723462452 (Personal)
Permalink: http://viaf.org/viaf/49163629022723462452
Preferred Forms
- 100 1 _ ‡a Faust, Saul
-
- 100 0 _ ‡a Saul N Faust
4xx's: Alternate Name Forms (4)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Future of flu vaccines. Expediting clinical trials in a pandemic | |
Good outlook for patients with confirmed Lyme neuroborreliosis | |
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study | |
Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease | |
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults. | |
High frequency of paediatric facial nerve palsy due to Lyme disease in a geographically endemic region | |
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. | |
Identification of novel pneumolysin alleles from paediatric carriage isolates of Streptococcus pneumoniae. | |
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial | |
Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria | |
The Impact of Pediatric Outpatient Parenteral Antibiotic Therapy Implementation at a Tertiary Children's Hospital in the United Kingdom. | |
Infectious purpura fulminans: caution needed in the use of protein C. | |
Intracellular residency of Staphylococcus aureus within mast cells in nasal polyps: A novel observation. | |
Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome. | |
Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model | |
It's Time to Put Children and Young People First During the Global COVID-19 Pandemic | |
Lack of evidence for an unmet need to treat Clostridium difficile infection in infants aged <2 years: expert recommendations on how to address this issue | |
Linezolid an oral treatment option for staphylococcal liver abscess in chronic granulomatous disease | |
Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland. | |
Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance. | |
Managing abnormal clotting in intensive care | |
Managing bone and joint infection in children | |
Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function | |
Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy | |
Microbial analysis of the upper respiratory tract to support the development of effective vaccine policy: a population-based pilot study | |
Microbial epidemiology and carriage studies for the evaluation of vaccines | |
Mucosal-Associated Invariant T (MAIT) Cells Are Impaired in Th17 Associated Primary and Secondary Immunodeficiencies | |
Mutations in RPSA and NKX2-3 link development of the spleen and intestinal vasculature | |
Nasal self-swabbing for estimating the prevalence of Staphylococcus aureus in the community. | |
New approaches to the treatment of biofilm-related infections. | |
New therapies for treating infections in infants and children | |
Nitric oxide-mediated dispersal and enhanced antibiotic sensitivity in pseudomonas aeruginosa biofilms from the cystic fibrosis lung | |
Non-alcoholic liver disease and childhood obesity | |
Opa protein repertoires of disease-causing and carried meningococci | |
Opportunities for paediatricians to do research with the National Institute for Health Research | |
Opsoclonus-myoclonus syndrome associated with group a streptococcal infection | |
Paper-based colorimetric enzyme linked immunosorbent assay fabricated by laser induced forward transfer. | |
Pathophysiology of meningococcal meningitis and septicaemia | |
Phase I studies: the role of publicly funded academic-healthcare partnerships | |
Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants. | |
Picture of the month: spinal and scapular tuberculosis | |
Platelet and soluble CD40L in meningococcal sepsis. | |
Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults. | |
Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial | |
Pneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzae | |
Polymorphisms in PARP, IL1B, IL4, IL10, C1INH, DEFB1, and DEFA4 in meningococcal disease in three populations | |
Positioning Children's Voice in Clinical Trials Research: A New Model for Planning, Collaboration, and Reflection. | |
Pre-vaccine serotype composition within a lineage signposts its serotype replacement - a carriage study over 7 years following pneumococcal conjugate vaccine use in the UK. | |
Precision Molecular Diagnosis Defines Specific Therapy in Combined Immunodeficiency with Megaloblastic Anemia Secondary to MTHFD1 Deficiency | |
Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome. | |
Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans | |
Prescribing for children - taste and palatability affect adherence to antibiotics: a review | |
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons | |
Primary ciliary dyskinesia ciliated airway cells show increased susceptibility to Haemophilus influenzae biofilm formation. | |
Problem-solving in clinical practice: Persisting respiratory distress in a premature infant | |
Pronounced metabolic changes in adaptation to biofilm growth by Streptococcus pneumoniae | |
Protocol for a controlled human infection with genetically modified expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine | |
Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches | |
Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial | |
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series | |
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group | |
Research Evaluation Alongside Clinical Treatment in COVID-19 (REACT COVID-19): an observational and biobanking study | |
Respiratory tract infection associated with seizures. | |
Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia | |
The rise and fall of pneumococcal serotypes carried in the PCV era. | |
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP | |
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study | |
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study | |
Sampling methods for the study of pneumococcal carriage: a systematic review. | |
Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT. | |
Severe Enterovirus Infections in Hospitalized Children in the South of England: Clinical Phenotypes and Causative Genotypes | |
Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet-neutrophil complexes. | |
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials | |
Sleeping sickness in brothers in london. | |
Stroke in paediatric pneumococcal meningitis: a cross-sectional population-based study | |
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children | |
Suspected sepsis: summary of NICE guidance | |
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy. | |
Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study* | |
Varicella zoster virus central nervous system immune reconstitution inflammatory syndrome presenting in a child. | |
Zakażenia i odporność = Infection and immunity |